Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary?

Jien Jiun Chen; Lian Yu Lin; Yao Hsu Yang; Juey Jen Hwang; Pau Chung Chen; Jiunn Lee Lin

doi:10.1016/j.ijcard.2015.05.162

Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary?

Jien Jiun Chen, Lian Yu Lin, Yao Hsu Yang, Juey Jen Hwang, Pau Chung Chen^*, Jiunn Lee Lin

^*Corresponding author for this work

Research output: Contribution to journal › Journal Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	53
Number of pages	1
Journal	International Journal of Cardiology
Volume	196
DOIs	https://doi.org/10.1016/j.ijcard.2015.05.162
State	Published - 23 07 2015
Externally published	Yes

Keywords

Aspirin stroke
Atrial fibrillation
Coumadin
End-stage renal disease

Access to Document

10.1016/j.ijcard.2015.05.162

Cite this

@article{91bae3c7d0f345bdb55253ab3d84a7cc,

title = "Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary?",

keywords = "Aspirin stroke, Atrial fibrillation, Coumadin, End-stage renal disease",

author = "Chen, {Jien Jiun} and Lin, {Lian Yu} and Yang, {Yao Hsu} and Hwang, {Juey Jen} and Chen, {Pau Chung} and Lin, {Jiunn Lee}",

year = "2015",

month = jul,

day = "23",

doi = "10.1016/j.ijcard.2015.05.162",

language = "英语",

volume = "196",

pages = "53",

journal = "International Journal of Cardiology",